CHONRAD - Evaluation of efficacy and safety of Évérolimus as neo-adjuvant therapy in chondrosarcoma patients: phase IIa, prospective, multicentric, open-label.
FunderInstitut National du Cancer
Funded underPHRC
Call for proposalPHRC11
Project codeINCa-DGOS-3761
Open Access mandatePublications: NoResearch data: No